The results have confirmed that CD4+ and CD8+ T cell responses could be expanded in pancreatic cancer patients, and that these patients had an increased frequency of IFN-γ secreting CD4+ T cells, compared to the controls. This evidence concerns the gene CD4 and familial pancreatic carcinoma.